{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:56:53Z","timestamp":1793361413805,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-06092-9","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T09:02:21Z","timestamp":1779872541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Machine-learning algorithms identify sTREM1 as a key biomarker for outcome prediction in critically ill"],"prefix":"10.1186","volume":"30","author":[{"given":"Charles","family":"de Roquetaillade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Louis","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Uhel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Cartailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Van Der Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Gayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chousterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"6092_CR1","doi-asserted-by":"publisher","unstructured":"Ranzani OT, Singer M, Salluh JIF, Shankar-Hari M, Pilcher D, Berger-Estilita J, et al. Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score. JAMA. 2025 Oct;29. https:\/\/doi.org\/10.1001\/jama.2025.20516.","DOI":"10.1001\/jama.2025.20516"},{"issue":"24","key":"6092_CR2","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.270.24.2957","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA. 1993;270(24):2957\u201363. https:\/\/doi.org\/10.1001\/jama.270.24.2957 . PubMed PMID: 8254858.","journal-title":"JAMA"},{"key":"6092_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mib.2015.11.003","volume":"29","author":"KA Kline","year":"2016","unstructured":"Kline KA, Bowdish DM. Infection in an aging population. Curr Opin Microbiol. 2016;29:63\u20137. https:\/\/doi.org\/10.1016\/j.mib.2015.11.003.","journal-title":"Curr Opin Microbiol"},{"issue":"7","key":"6092_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707\u201310. https:\/\/doi.org\/10.1007\/BF01709751 . PubMed PMID: 8844239.","journal-title":"Intensive Care Med"},{"issue":"1","key":"6092_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13054-020-02913-7","volume":"24","author":"P van der Zee","year":"2020","unstructured":"van der Zee P, Rietdijk W, Somhorst P, Endeman H, Gommers D. A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality. Crit Care. 2020;24(1):243. https:\/\/doi.org\/10.1186\/s13054-020-02913-7.","journal-title":"Crit Care"},{"issue":"1","key":"6092_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13054-021-03862-5","volume":"26","author":"T Barichello","year":"2022","unstructured":"Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Biomarkers for sepsis: more than just fever and leukocytosis\u2014a narrative review. Crit Care. 2022;26(1):14. https:\/\/doi.org\/10.1186\/s13054-021-03862-5.","journal-title":"Crit Care"},{"issue":"10","key":"6092_CR7","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1007\/s00134-024-07586-2","volume":"50","author":"M Girardis","year":"2024","unstructured":"Girardis M, David S, Ferrer R, Helms J, Juffermans NP, Martin-Loeches I, et al. Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis. Intensive Care Med. 2024;50(10):1580\u201392. https:\/\/doi.org\/10.1007\/s00134-024-07586-2 . PubMed PMID: 39222142.","journal-title":"Intensive Care Med"},{"issue":"1","key":"6092_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","volume":"16","author":"NL Stanski","year":"2020","unstructured":"Stanski NL, Wong HR. Prognostic and predictive enrichment in sepsis. Nat Rev Nephrol. 2020;16(1):20\u201331. https:\/\/doi.org\/10.1038\/s41581-019-0199-3.","journal-title":"Nat Rev Nephrol"},{"key":"6092_CR9","doi-asserted-by":"publisher","unstructured":"Venet F, Textoris J, Blein S, Rol ML, Bodinier M, Canard B, et al. Immune Profiling Demonstrates a Common Immune Signature of Delayed Acquired Immunodeficiency in Patients With Various Etiologies of Severe Injury. Crit Care Med. 2021 Nov;10. https:\/\/doi.org\/10.1097\/CCM.0000000000005270 . PubMed PMID: 34534131.","DOI":"10.1097\/CCM.0000000000005270"},{"issue":"25","key":"6092_CR10","doi-asserted-by":"publisher","first-page":"00241","DOI":"10.1016\/j.immuni.2025.05.020","volume":"S1074\u20137613","author":"A Ganesan","year":"2025","unstructured":"Ganesan A, Moore AR, Zheng H, Toh J, Freedman M, Magis AT, et al. A conserved immune dysregulation signature is associated with infection severity, risk factors prior to infection, and treatment response. Immunity. 2025;S1074\u20137613(25):00241\u20139. https:\/\/doi.org\/10.1016\/j.immuni.2025.05.020 . PubMed PMID: 40532705.","journal-title":"Immunity"},{"key":"6092_CR11","doi-asserted-by":"publisher","unstructured":"Moore AR, Zheng H, Ganesan A, Hasin-Brumshtein Y, Maddali MV, Levitt JE, et al. A consensus immune dysregulation framework for sepsis and critical illnesses. Nat Med. 2025;1\u201313. https:\/\/doi.org\/10.1038\/s41591-025-03956-5.","DOI":"10.1038\/s41591-025-03956-5"},{"issue":"6","key":"6092_CR12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","volume":"28","author":"DM Maslove","year":"2022","unstructured":"Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, et al. Redefining critical illness. Nat Med. 2022;28(6):1141\u20138. https:\/\/doi.org\/10.1038\/s41591-022-01843-x.","journal-title":"Nat Med"},{"issue":"1","key":"6092_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13054-017-1922-8","volume":"22","author":"E Gayat","year":"2018","unstructured":"Gayat E, Cariou A, Deye N, Vieillard-Baron A, Jaber S, Damoisel C, et al. Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study. Crit Care. 2018;22(1):8. https:\/\/doi.org\/10.1186\/s13054-017-1922-8.","journal-title":"Crit Care"},{"issue":"1","key":"6092_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00134-021-06574-0","volume":"48","author":"H Peters-Sengers","year":"2022","unstructured":"Peters-Sengers H, Butler JM, Uhel F, Schultz MJ, Bonten MJ, Cremer OL, et al. Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study. Intensive Care Med. 2022;48(1):92\u2013102. https:\/\/doi.org\/10.1007\/s00134-021-06574-0 . PubMed PMID: 34902047; PubMed Central PMCID: PMC8667541.","journal-title":"Intensive Care Med"},{"issue":"11","key":"6092_CR15","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2004090740","volume":"16","author":"GM Chertow","year":"2005","unstructured":"Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol JASN. 2005;16(11):3365\u201370. 10. 1681\/ASN.2004090740 PubMed PMID: 16177006.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"6","key":"6092_CR16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1164\/rccm.201910","volume":"202","author":"F D\u00e9pret","year":"2020","unstructured":"D\u00e9pret F, Hollinger A, Cariou A, Deye N, Vieillard-Baron A, Fournier MC, et al. Incidence and Outcome of Subclinical Acute Kidney Injury Using penKid in Critically Ill Patients. Am J Respir Crit Care Med. 2020;202(6):822\u20139. https:\/\/doi.org\/10.1164\/rccm.201910. -1950OC PubMed PMID: 32516543.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"6092_CR17","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","volume":"164","author":"A Bouchon","year":"2000","unstructured":"Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol Baltim Md 1950. 2000;164(10):4991\u20135. https:\/\/doi.org\/10.4049\/jimmunol.164.10.4991 . PubMed PMID: 10799849.","journal-title":"J Immunol Baltim Md 1950"},{"issue":"5","key":"6092_CR18","doi-asserted-by":"publisher","first-page":"e010314","DOI":"10.1136\/bmjopen-2015-010314","volume":"6","author":"L Su","year":"2016","unstructured":"Su L, Liu D, Chai W, Liu D, Long Y. Role of sTREM-1 in predicting mortality of infection: a systematic review and meta-analysis. BMJ Open. 2016;6(5):e010314. https:\/\/doi.org\/10.1136\/bmjopen-2015-010314 . PubMed PMID: 27178971.","journal-title":"BMJ Open"},{"issue":"1","key":"6092_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s43856-025-01014-2","volume":"5","author":"N Balanza","year":"2025","unstructured":"Balanza N, Baro B, Ajanovic S, Boca Z, Bramugy J, Cossa A, et al. Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) predicts mortality in patients with febrile illness in southern Mozambique. Commun Med. 2025;5(1):310. https:\/\/doi.org\/10.1038\/s43856-025-01014-2.","journal-title":"Commun Med"},{"key":"6092_CR20","doi-asserted-by":"publisher","unstructured":"Moore AR, Zheng H, Ganesan A, Hasin-Brumshtein Y, Maddali MV, Levitt JE, van der Poll T, Lu J, Bouma HR, Scicluna BP, Giamarellos-Bourboulis EJ, Kotsaki A, Martin-Loeches I, Garduno A, Hinson J, Rothman RE, Sevransky J, Wright DW, Atreya MR, Moldawer LL, Efron PA, Kralovcova M, Karvunidis T, Giannini HM, Meyer NJ, Sweeney TE, Rogers AJ, Khatri P. A consensus immune dysregulation framework for sepsis and critical illnesses. Nat Med. 2025 Dec;31(12):4084-4096. 10.1038\/s41591-025-03956-5. Epub 2025 Sep 30. Erratum in: Nat Med. 2025 Dec;31(12):4313. 10.1038\/s41591-025-04066-y. PMID: 41028543; PMCID: PMC12705441. https:\/\/doi.org\/10.1038\/s41591-025-03956-","DOI":"10.1038\/s41591-025-03956-"},{"issue":"5","key":"6092_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/cc3732","volume":"9","author":"S Gibot","year":"2005","unstructured":"Gibot S. Clinical review: Role of triggering receptor expressed on myeloid cells-1 during sepsis. Crit Care. 2005;9(5):485\u20139. doi:10.1186\/cc3732 PubMed PMID: 16277737; PubMed Central PMCID: PMC1297602.","journal-title":"Crit Care"},{"issue":"8","key":"6092_CR22","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/s41423-021-00733-5","volume":"18","author":"L Jolly","year":"2021","unstructured":"Jolly L, Carrasco K, Salcedo-Magguilli M, Garaud JJ, Lambden S, van der Poll T, et al. sTREM-1 is a specific biomarker of TREM-1 pathway activation. Cell Mol Immunol. 2021;18(8):2054\u20136. https:\/\/doi.org\/10.1038\/s41423-021-00733-5.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"6092_CR23","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.4049\/jimmunol.1102674","volume":"188","author":"M Derive","year":"2012","unstructured":"Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, et al. Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol Baltim Md 1950. 2012;188(11):5585\u201392. https:\/\/doi.org\/10.4049\/jimmunol.1102674 . PubMed PMID: 22551551; PubMed Central PMCID: PMC6382278.","journal-title":"J Immunol Baltim Md 1950"},{"issue":"2","key":"6092_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/SHK.0b013e31827bcdfb","volume":"39","author":"M Derive","year":"2013","unstructured":"Derive M, Boufenzer A, Bouazza Y, Groubatch F, Alauzet C, Barraud D, et al. Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs. Shock Augusta Ga. 2013;39(2):176\u201382. https:\/\/doi.org\/10.1097\/SHK.0b013e31827bcdfb . PubMed PMID: 23324887.","journal-title":"Shock Augusta Ga"},{"issue":"4","key":"6092_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/ALN.0000000000000078","volume":"120","author":"M Derive","year":"2014","unstructured":"Derive M, Boufenzer A, Gibot S. Attenuation of responses to endotoxin by the triggering receptor expressed on myeloid cells-1 inhibitor LR12 in nonhuman primate. Anesthesiology. 2014;120(4):935\u201342. 10.1097. \/ALN.0000000000000078 PubMed PMID: 24270127.","journal-title":"Anesthesiology"},{"issue":"10","key":"6092_CR26","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-2600(","volume":"11","author":"B Fran\u00e7ois","year":"2023","unstructured":"Fran\u00e7ois B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, et al. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial. Lancet Respir Med. 2023;11(10):894\u2013904. https:\/\/doi.org\/10.1016\/S2213-2600(. 23)00158-3 PubMed PMID: 37269870.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"6092_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/SHK.0000000000001888","volume":"57","author":"NA Sathe","year":"2022","unstructured":"Sathe NA, Bhatraju PK, Mikacenic C, Morrell ED, Mabrey FL, Liles WC, et al. Relationships between age, soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), and mortality among critically ill adults: a cohort study. Shock Augusta Ga. 2022;57(2):205\u201311. .0000000000001888 PubMed PMID: 34812186; PubMed Central PMCID: PMC8969235.","journal-title":"Shock Augusta Ga"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06092-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:04:32Z","timestamp":1790640272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06092-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6092"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06092-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8554617\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The title contained minor errors in the original publication, this article has been updated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original FROG-ICU study was conducted in France and Belgium in accordance with Good Clinical Practice (Declaration of Helsinki 2002) and Ethical Committee approvals (Comit\u00e9 de Protection des Personnes\u2014Ile de France IV, IRB n\u00b000003835 and Commission d\u2019\u00e9thique biom\u00e9dicale hospitalo-facultaire de l\u2019h\u00f4pital de Louvain, IRB n\u00b0.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read the paper and gave their consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The assays were performed as part of the IMOCRIT research program, funded by Roche. BGC served as a member of a Roche Diagnostics advisory board and received no other fees. CdR received fees from Roche Diagnostics. Roche Diagnostics had no role in study design, data collection, data analysis, manuscript preparation, or the decision to submit the manuscript. The other authors declare no competing interests in relation to the present study.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"312"}}